Patents/Assignees

Parker Institute For Cancer Immunotherapy

2 patents in portfolio

US12202884utility2025
Nucleic Acids Encoding Switch Receptors Using IL-9 Receptor Signaling Domains
0 cites
US11780899utility2023
Engineered Proteins to Enhance Sensitivity of a Cell to IL-2
0 cites